Comparison between DDAVP-treated and non-treated groups in severe hyponatremia

Phase 3

Recruiting

• Conditions: Hyponatremia

• Registration Number: JPRN-jRCTs041220117
• Lead Sponsor: Iwata Mitsunaga

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-01-16
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

1.Patients aged 20 years or older at the time of obtaining consent
2.Patients diagnosed with hyponatremia based on the diagnostic criteria of a sodium level of 120 mEq/L or less in blood tests
3.Patients who have given their free written consent to participate in this study after receiving sufficient explanation and understanding

Exclusion Criteria

1. Patients on regular DDAVP medication
2. Patients taking oral tolvaptan
3. Patients with hyponatremia diagnosed as isotonic or hypertonic
4. Patients diagnosed with hypotonic hyponatremia who are diagnosed with heart failure according to 2021ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
5. Patients admitted towards other than ICU or ICU equivalent wards, and patients already hospitalized for other diseases
6. Other patients who are judged inappropriate by the principal investigator or sub-investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified